Business ❯ Pharmaceuticals ❯ Acquisitions

Merck

Cidara Therapeutics Springworks Therapeutics Verona Pharma

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

The purchase adds a late-stage, FDA-designated flu preventive to bolster Merck’s post‑Keytruda growth.

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy